Published • loading... • Updated
‘A chilling effect’: China biotech will slow as it nears R&D frontier, Pfizer’s Baum predicts
Summary by endpoints.news
2 Articles
2 Articles
China views biotechnology as a top priority and is thereby competing with the Dutch biotech sector. Biotech—the technical use of biology for purposes such as medicines, food, or new substances—is now mentioned in the same breath in China as the semiconductor and aerospace industries. The Dutch sector, on the other hand, is struggling with a lack of funding, insufficient investment in scientific education, and delaying regulations, lists medical …
·Hilversum, Netherlands (Kingdom of the)
Read Full Article
‘A chilling effect’: China biotech will slow as it nears R&D frontier, Pfizer’s Baum predicts
China’s rapid advance in biotech will slow as companies there begin to experiment on the cutting edge of R&D, according to Pfizer’s Andrew Baum, who expects the risks of biology and drug development will create ...
Coverage Details
Total News Sources2
Leaning Left0Leaning Right1Center0Last UpdatedBias Distribution100% Right
Bias Distribution
- 100% of the sources lean Right
100% Right
R 100%
Factuality
To view factuality data please Upgrade to Premium
